Cache Advisors LLC Makes New $523,000 Investment in Colgate-Palmolive Company $CL

Cache Advisors LLC bought a new position in Colgate-Palmolive Company (NYSE:CL) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 6,621 shares of the company’s stock, valued at approximately $523,000.

Other hedge funds have also added to or reduced their stakes in the company. Powers Advisory Group LLC raised its stake in shares of Colgate-Palmolive by 3.1% in the fourth quarter. Powers Advisory Group LLC now owns 8,926 shares of the company’s stock worth $705,000 after purchasing an additional 269 shares during the last quarter. Woodmont Investment Counsel LLC raised its stake in shares of Colgate-Palmolive by 7.4% in the fourth quarter. Woodmont Investment Counsel LLC now owns 3,707 shares of the company’s stock worth $293,000 after purchasing an additional 257 shares during the last quarter. Greenleaf Trust increased its position in Colgate-Palmolive by 11.4% during the fourth quarter. Greenleaf Trust now owns 38,029 shares of the company’s stock valued at $3,005,000 after acquiring an additional 3,901 shares during the last quarter. Capital Advisors Ltd. LLC increased its position in Colgate-Palmolive by 33.3% during the fourth quarter. Capital Advisors Ltd. LLC now owns 772 shares of the company’s stock valued at $61,000 after acquiring an additional 193 shares during the last quarter. Finally, Stock Yards Bank & Trust Co. increased its position in Colgate-Palmolive by 6.0% during the fourth quarter. Stock Yards Bank & Trust Co. now owns 15,005 shares of the company’s stock valued at $1,186,000 after acquiring an additional 843 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Analysts Set New Price Targets

CL has been the subject of a number of research reports. UBS Group reduced their price objective on Colgate-Palmolive from $100.00 to $98.00 and set a “buy” rating for the company in a research report on Tuesday. Piper Sandler cut their price target on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating for the company in a report on Wednesday. Morgan Stanley boosted their price target on Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a report on Monday, February 2nd. TD Cowen reissued a “hold” rating and set a $85.00 price target on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Finally, JPMorgan Chase & Co. boosted their price target on Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a report on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $95.13.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $85.54 on Thursday. The stock has a 50 day moving average of $91.04 and a 200 day moving average of $83.52. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The firm has a market cap of $68.63 billion, a PE ratio of 32.65, a PEG ratio of 3.91 and a beta of 0.34. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the company earned $0.91 EPS. On average, research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be issued a $0.53 dividend. The ex-dividend date is Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a dividend yield of 2.5%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 79.39%.

Insiders Place Their Bets

In related news, insider John Hazlin sold 20,989 shares of the stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the transaction, the insider owned 17,645 shares of the company’s stock, valued at $1,663,041.25. This represents a 54.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the sale, the insider directly owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. This trade represents a 53.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 184,683 shares of company stock valued at $17,486,693. Corporate insiders own 0.34% of the company’s stock.

Trending Headlines about Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: UBS trimmed its price target to $98 (from $100) but kept a Buy rating, signaling continued conviction in Colgate’s fundamentals and supporting demand among buy‑side investors. UBS lowers price target to $98 but keeps Buy
• Positive Sentiment: Colgate‑Palmolive was included on a list of best low‑volatility blue‑chip stocks, reinforcing its defensive/steady‑growth narrative (appealing to income and risk‑averse investors given CL’s low beta). InsiderMonkey low‑volatility list
• Positive Sentiment: Analysts’ consensus remains above neutral (reported as a “Moderate Buy”), which helps sustain investor confidence despite some target cuts. Consensus Moderate Buy report
• Neutral Sentiment: Piper Sandler lowered its target from $96 to $92 but maintained an Overweight rating — a mixed signal that trims upside expectations while still backing the stock. Piper Sandler cuts target to $92, keeps Overweight Benzinga
• Negative Sentiment: Wells Fargo cut its price target to $92 and moved to an Equal Weight rating — a clearer downside pressure on near‑term sentiment because it reduces the analyst‑driven upside case. Wells Fargo cuts target to $92, downgrades to EW

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.